ac investment research

NASDAQ:NRBO Stock Forecast, Price Targets (Buy or Sell) | NRBO NeuroBo Pharmaceuticals Analyst Ratings



We believe that when a company is viewed as being on the cusp between two liquidity descriptors and has higher-than-average cash plus inventory/unadjusted debt compared with similarly constituted peers, that helps support the better liquidity assessment. However, in the case of a nonresidential developer, given that its inventory is typically less liquid (and the greater potential for inventory to suffer value erosion in a downturn), we do not consider this measure as pertinent.

We estimate NRBO NeuroBo Pharmaceuticals stock forecast parameters by: FS with Wilcoxon Sign-Rank Test



NRBO NeuroBo Pharmaceuticals Stock Forecast (Buy or Sell) as of 26 May 2022 for (n+7)

Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network with FS and Wilcoxon Sign-Rank Test. Machine Learning based stock forecast (n+7) for NRBO NeuroBo Pharmaceuticals as below:

Time series to forecast n: 26 May 2022 for (n+7)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %


AC Investment Research

In our experiment, we focus on an approach known as Decision making using game theory. We apply principles from game theory to model the relationships between rating actions, news, market signals and decision making.

301 Massachusetts Avenue Cambridge, MA 02139 667-253-1000 pr@ademcetinkaya.com